Home Association of polymorphisms of PTGS2 and CYP8A1 with myocardial infarction
Article
Licensed
Unlicensed Requires Authentication

Association of polymorphisms of PTGS2 and CYP8A1 with myocardial infarction

  • Xiang Xie , Yi-tong Ma , Zhen-yan Fu , Yi-ning Yang , Xiang Ma , Bang-dang Chen , Ying-hong Wang and Fen Liu
Published/Copyright: March 1, 2009

Abstract

Background: Cyclooxygenase-2 (COX-2) and prostacyclin synthase (PGIS) are enzymes involved in prostaglandin and prostacyclin synthesis, which have been linked to cardiovascular disease risk. We hypothesized that genetic variations altering the function of these enzymes would modify the risk of myocardial infarction (MI).

Methods: In a Chinese case control study of MI patients (n=356) and healthy controls (n=350), we investigated the roles of polymorphisms in the PGIS gene (CYP8A1) and the COX-2 gene (PTGS2) using polymerase chain reaction-restriction fragment length polymorphism analysis.

Results: The CC genotype of CYP8A1 and the –765CC genotype of PTGS2 were more common in the MI patients than in the control subjects (p=0.041, p=0.012, respectively). The odds ratio (OR) estimated by the combined analysis for the CYP8A1 CC and PTGS2 –765CC genotypes [OR=5.44; 95% confidence interval (CI): 3.12–7.23] was markedly higher than that estimated separately for the CYP8A1 CC genotype (OR=1.37; 95% CI: 0.95–2.85) or the PTGS2 –765CC genotype (OR=2.92; 95% CI: 1.78–5.76) alone.

Conclusions: The CC genotype of CYP8A1 or the –765CC genotype of PTGS2 is associated with MI, respectively. Furthermore, the significantly combined effects of these two gene variants in the arachidonic acid metabolic pathway indicate that combining the effects of a modest number of genes, whose products are known to act in a pathophysiological manner, could be a useful method to explore the association of genetic polymorphisms and polygenic inheritance disease.

Clin Chem Lab Med 2009;47:347–52.


Corresponding author: Yi-tong Ma, Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, PR China Phone: +86-991-4366169, Fax: +86-991-4366169,

Received: 2008-10-1
Accepted: 2008-12-29
Published Online: 2009-03-01
Published in Print: 2009-03-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Dipeptidyl peptidases and related proteins: Editorial
  2. Dipeptidyl peptidases and related proteins: multifaceted markers and therapeutic targets
  3. Dipeptidyl peptidases and related proteins: Reviews
  4. Dipeptidyl-peptidase IV and B-type natriuretic peptide. From bench to bedside
  5. Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions
  6. Dipeptidyl peptidase (DP) 6 and DP10: novel brain proteins implicated in human health and disease
  7. Dipeptidyl peptidases and related proteins: Original Papers
  8. Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice
  9. Original Papers
  10. Phenotyping of congenic dipeptidyl peptidase 4 (DP4) deficient Dark Agouti (DA) rats suggests involvement of DP4 in neuro-, endocrine, and immune functions
  11. Genetics and Molecular Diagnostics
  12. A selected pre-amplification strategy for genetic analysis using limited DNA targets
  13. Automated cell disruption is a reliable and effective method of isolating RNA from fresh snap-frozen normal and malignant oral mucosa samples
  14. General Clinical Chemistry and Laboratory Medicine
  15. Serum free light chain immunoassay as an adjunct to serum protein electrophoresis and immunofixation electrophoresis in the detection of multiple myeloma and other B-cell malignancies
  16. Gas chromatography/mass spectrometry screening of serum metabolomic biomarkers in hepatitis B virus infected cirrhosis patients
  17. Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers
  18. Sensitive and specific ELISA coated by TpN15-TpN17-TpN47 fusion protein for detection of antibodies to Treponema pallidum
  19. Cardiovascular Diseases
  20. Expression of heme oxygenase-1, hypoxia inducible factor-1α, and ubiquitin in peripheral inflammatory cells from patients with coronary heart disease
  21. Vitamin B12 deficiency is associated with coronary artery disease in an Indian population
  22. Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease
  23. Association of polymorphisms of PTGS2 and CYP8A1 with myocardial infarction
  24. Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes
  25. Validation and Outcome Studies
  26. Evaluation of the BD Vacutainer® PST™ II Blood Collection Tube for special chemistry analytes
  27. Higher parathyroid hormone (PTH) concentrations with the Architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods
  28. Precision performance at low levels and 99th percentile concentration of the Access® AccuTnI® assay on two different platforms
  29. Guidelines and Recommendations
  30. The European Register of Specialists in Clinical Chemistry and Laboratory Medicine: Code of Conduct, Version 2 – 2008
  31. Letters to the Editor
  32. A preliminary evaluation of the AQT90 FLEX TnI immunoassay
  33. Automated validation of clinical laboratory test results: do we get what we expect?
  34. The degree of knowledge shown by physicians in relation to the variability of laboratory test results
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.078/html?lang=en
Scroll to top button